Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases

Objective Evaluate spondyloarthritis (SpA) incidence in inflammatory bowel diseases (IBD) between patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional DMARDs (cDMARDs) and define risk factors associated with SpA development.Methods Retrospective cohort st...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Paola Conigliaro, Maria Sole Chimenti, Paola Triggianese, Alberto Bergamini, Mauro Fatica, Benedetta Monosi, Arianna D’Antonio, Sara Essofi, Elisa Cuccagna, Livia Biancone, Giovanni Monteleone, Emma Calabrese
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 2024-02-01
Schriftenreihe:	RMD Open
Online-Zugang:	https://rmdopen.bmj.com/content/10/1/e003820.full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!